Patent ID: 6986901

Claim:
A composition for treating or gastrointestinal disorders, comprising: a.) a safe and effective amount of an amino-ether and/or -ester oxide having the formula: in which: R 1 is a lower alkyl, R 2 and R 3 which are the same or different are hydrogen or lower alkyl, R 4 is a phenyl or phenoxy nucleus optionally monosubstituted to trisubstituted by substituents which are identical or different, halogen or lower alkoxy, R 5 is a phenyl radical optionally monosubstituted to trisubstituted by substituents which are the same or different, halogen, lower alkyl, lower alkoxy or nitro, a pyridyl radical or a lower alkyl radical, Q is —O— or —COO—, n is equal to zero 1 or 2, m and q are, independently of one another, equal to zero or to 1, wherein the amino-ether and/or -ester oxide is selected from the group consisting of trimebutine, fedotozine and mixtures thereof; and b.) a safe and effective amount of a gastrointestinal active selected from the group consisting of laxatives, antidiarrheals, antibiotics, antiulceratives, gastric secretion inhibitors, peristalitc stimulants, serotonin (5HT 3 ) receptor antagonists, serotonin (5HT 4 ) receptor agonists, selective serotonin reuptake inhibitor and mixture thereof; and c.) an anti-inflammatory compound.